Thomas Perkmann

6.8k citations

121 papers · 3.1k indexed · h-index 28

Impact in

Internal Medicine top 5%
Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases

Papers in

Immunology 31
- Atherosclerosis and Cardiovascular Diseases 9
- Immunodeficiency and Autoimmune Disorders 6
Infectious Diseases 26
- SARS-CoV-2 and COVID-19 Research 23
- COVID-19 Clinical Research Studies 15
- SARS-CoV-2 detection and testing 6

Co-authors: Helmuth Haslacher Oswald Wagner Christoph J. Binder Georg Endler Joseph L. Witztum Sohvi Hörkkö Karsten Hartvigsen Claudia Marsik
Journals: PLoS ONE (8 papers)European Journal of Clinical Investigation (5 papers)Scientific Reports (4 papers)Blood (4 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)
Partner nations: Austria United States Germany

In The Last Decade

Thomas Perkmann

114 papers receiving 3.1k citations

Peers

Countries citing papers authored by Thomas Perkmann

Since Specialization

Citations

This map shows the geographic impact of Thomas Perkmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Perkmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Perkmann more than expected).

Fields of papers citing papers by Thomas Perkmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Perkmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Perkmann. The network helps show where Thomas Perkmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Perkmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Perkmann Line = papers co-authored together Thomas Perkmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study BMJ Open ·Elisabeth Simader, Felix Kartnig, Selma Tobudic, Daniel Mrak, Frank D. Walters, Thomas Karonitsch, Helmuth Haslacher, Thomas Perkmann, 寂然長野, Stefan Winkler, Daniel Aletaha, M Kortas, Péter Mandl	2025	0
2	Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains Vaccines ·A. Jenhani, 文森武, Bernhard Kratzer, Pia Gattinger, S. el-Seifi, Evelyn Gómez-Rada, Doris Trapin, Glauco F. Henriques, Ulrike Körmöczi, Arno Rottal, Zübeyde Şentürk Ulucak, Yulia Dorofeeva, Inna Tulaeva, Milena Weber, Katharina Grabmeier‐Pfistershammer, Thomas Perkmann, Ursula Wiedermann, Rudolf Valenta, Winfried F. Pickl	2024	1
3	Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19 Allergy ·Bernhard Kratzer, Pia Gattinger, Doris Trapin, Glauco F. Henriques, Ulrike Körmöczi, Arno Rottal, S. el-Seifi, A. Jenhani, Suzhao Zou, Zübeyde Şentürk Ulucak, Inna Tulaeva, Katharina Grabmeier‐Pfistershammer, Matsuo MATSUURA, Thomas Perkmann, Ingrid Faé, Sabine Wenda, Michael Kundi, Gottfried Fischer, Rudolf Valenta, Winfried F. Pickl	2024	14
4	The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination Frontiers in Medicine ·Selma Tobudic, Elisabeth Simader, Frank D. Walters, 魏志福, Felix Kartnig, Leonhard X. Heinz, Péter Mandl, Helmuth Haslacher, Thomas Perkmann, Lisa Schneider, Thomas Nothnagl, Helga Radner, Ka Tung Lau, Heinz Burgmann, Karin Stiasny, Gottfried Novacek, Walter Reinisch, Daniel Aletaha, Stefan Winkler, Stephan Blüml	2023	5
5	Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial Infectious Agents and Cancer ·Maximilian J. Mair, Müge Güleli, Feng-de Xi, Rainer Puhr, R Zandin, Marlene Troch, Hannah Christina Puhr, Angelika M. Starzer, Ariane Steindl, Е Н Быкова, Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer	2023	1
6	Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria BMJ Open ·Martin Riesenhuber, Christian Nitsche, Christoph J. Binder, Eva Schernhammer, Tanja Stamm, Heeyoun Cho, Fatema K Mujpurwala, I. Ogoh, Helmuth Haslacher, Thomas Perkmann, Christian Hengstenberg, Thomas A. Zelniker	2023	1
7	Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability Clinical Chemistry and Laboratory Medicine (CCLM) ·Văn San Lê, Patrick Mucher, P Schmidt, Astrid Radakovics, Jeon Su-Han, Philipp Hofer, Thomas Perkmann, Ai Thu, Klaus G. Schmetterer, Helmuth Haslacher	2022	10
8	Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant Microbiology Spectrum ·Mengsen Zhang, Thomas Perkmann, Jin Miao, Patrick Mucher, S LGross, Rodrig Marculescu, Darlane Amorim Vieira, Jeremy V. Camp, Marianne Graninger, Kaitlyn Rath, Xia Xiju, บุญเสริม เนตรเก่ง, Stephan W. Aberle, Elisabeth Puchhammer‐Stöckl, Helmuth Haslacher, 美鈴赤星, Judith H. Aberle, Karin Stiasny, Lukas Weseslindtner	2022	19
9	Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes Allergy ·Victoria Garib, Meriem Ben‐Ali, Michael Kundi, Mirela Curin, Ivan Fernandez, Imen Ben‐Mustapha, Najla Mekki, Neil C. Fernandez, Thomas Perkmann, Rudolf Valenta, Mohamed‐Ridha Barbouche	2021	5
10	Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity Clinical Chemistry ·Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, Robab Breyer‐Kohansal, Otto C. Burghuber, Sylvia Hartl, Daniel Aletaha, Daniela Sieghart, Peter Quehenberger, Rodrig Marculescu, Patrick Mucher, Robert Straßl, Oswald Wagner, Christoph J. Binder, Helmuth Haslacher	2020	80
11	Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank Biopreservation and Biobanking ·Helmuth Haslacher, Marlene C. Gerner, Philipp Hofer, 赵秋歌, Johannes A. Hainfellner, Renate Kain, Oswald Wagner, Thomas Perkmann	2018	63
12	The usefulness of CYFRA 21–1 to diagnose and predict preeclampsia: a nested case-control study BMC Pregnancy and Childbirth ·Lorenz Kuessel, Harald Zeisler, Robin Ristl, Julia Binder, Petra Pateisky, Maximilian Schmid, Julian Marschalek, Thomas Perkmann, Helmuth Haslacher, H Husslein	2016	6
13	A Risk Prediction Model for Screening Bacteremic Patients: A Cross Sectional Study PLoS ONE ·Franz Ratzinger, Safana Nur Rizky, Maharjan Pranim, Thomas Perkmann, Heinz Burgmann, Athanasios Makristathis, Georg Dorffner, Felix Lötsch, Alexander Blacky, Michael Ramharter	2014	21
14	Reagent-free monitoring of multiple clinically relevant parameters in human blood plasma using a mid-infrared quantum cascade laser based sensor system The Analyst ·Markus Brandstetter, Vânia da Silva, B.K. Sharath, Andreas E. Posch, Christoph Herwig, Andreas Drolz, Valentin Fuhrmann, Thomas Perkmann, Bernhard Lendl	2013	52
15	Usefulness of Pre-Operative Copeptin Concentrations to Predict Post-Operative Outcome After Major Vascular Surgery Journal of Vascular Surgery ·Róbert Járai, Elisabeth Mahla, Thomas Perkmann	2012	2
16	Complementary Role of Copeptin and High-Sensitivity Troponin in Predicting Outcome in Patients with Stable Chronic Heart Failure European Journal of Heart Failure ·Ioannis Tentzeris, Rudolf Járai, Serdar Farhan, Thomas Perkmann, Michael Schwarz, Gabriele Jakl, Johann Wojta, Kurt Huber	2011	77
17	Cognitive function in elderly marathon runners: Cross-sectional data from the marathon trial (apsoem) Wiener klinische Wochenschrift ·Robert Winker, Jera Marušič, Thomas Perkmann, Helmuth Haslacher, GR Nascimento, Johann Lehrner, D. Tscholakoff, Peter Dal‐Bianco	2010	30
18	Bβ15–42 Protects against Acid-induced Acute Lung Injury and Secondary Pseudomonas Pneumonia In Vivo American Journal of Respiratory and Critical Care Medicine ·Ulrich Matt, Joanna Warszawska, Michael Bauer, 袁世璋, Ildikó Mesteri, Bianca Doninger, Isabella Haslinger, Gernot Schabbauer, Thomas Perkmann, Christoph J. Binder, Francis Haslewood, Peter Petzelbauer, Sylvia Knapp	2009	28
19	Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa Microbes and Infection ·Stefan Winkler, Claudia Moscovici, Junxin Wei, Ayôla Akim Adégnika, Thomas Perkmann, Michael Ramharter, Peter G. Kremsner	2005	30
20	Circulating levels of the interleukin (IL)-4 receptor and of IL-18 in patients with malaria Cytokine ·Thomas Perkmann, H H Winkler, W. Graninger, Peter G. Kremsner, S. Winkler	2004	16

About Thomas Perkmann

Thomas Perkmann is a scholar working on Immunology, Infectious Diseases, Internal Medicine, Hematology and Clinical Biochemistry, having authored 121 papers that have together received 3.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (23 papers), COVID-19 Clinical Research Studies (15 papers), Atherosclerosis and Cardiovascular Diseases (9 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), SARS-CoV-2 detection and testing (6 papers), Clinical Laboratory Practices and Quality Control (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). The work is most often cited by research in Internal Medicine (138 citations), Immunology (762 citations), Infectious Diseases (663 citations), Hepatology (236 citations) and Hematology (242 citations). Thomas Perkmann has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Helmuth Haslacher, Oswald Wagner, Christoph J. Binder, Georg Endler, Joseph L. Witztum, Sohvi Hörkkö, Karsten Hartvigsen, Claudia Marsik, Stefan Greisenegger and Linda Fogelstrand. Their work appears in journals such as PLoS ONE, European Journal of Clinical Investigation, Scientific Reports, Blood and Clinical Chemistry and Laboratory Medicine (CCLM).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact